During the past decade, Institutul Regional de Oncologie Iasi conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 15 clinical trials were completed, i.e. on average, 53.6% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 8 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institutul Regional de Oncologie Iasi" #1 sponsor was "Amgen" with 6 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Daiichi Sankyo, Inc." with 2 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored and "Institut de Recherches Internationales Servier" with 2 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institutul Regional de Oncologie Iasi" #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "BeiGene, Ltd." with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Institutul Regional de Oncologie Iasi" are "Metastatic Colorectal Cancer" (3 trials), "Breast Cancer" (2 trials), "Chemotherapy-induced Thrombocytopenia" (2 trials), "Non-small Cell Lung Cancer" (2 trials) and "Advanced Breast Cancer" (1 trials). Many other conditions were trialed in "Institutul Regional de Oncologie Iasi" in a lesser frequency.

Most popular intervention types in "Institutul Regional de Oncologie Iasi" are "Drug" (37 trials), "Biological" (4 trials), "Other" (4 trials), "Diagnostic Test" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (7 trials), "Placebo" (7 trials), "Capecitabine" (5 trials), "Carboplatin" (5 trials) and "Cisplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Institutul Regional de Oncologie Iasi" are 36 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Institutul Regional de Oncologie Iasi". undefined are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Institutul Regional de Oncologie Iasi, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Institutul Regional de Oncologie Iasi, 3 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Institutul Regional de Oncologie Iasi has several departments that took part in Clinical trials: "Institutul Regional de Oncologie Iasi; Clinica de Hematologie" - 6 trials